Show items per page
Elements: 7
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy Jakobsen, Håvard; Hannesdottir, Solveig; Bjarnarson, Stefania P; Schulz, Dominique; ... Jonsdottir, Ingileif 2006
add to browser selection
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts Bossen, Claudia; Cachero, Teresa G.; Tardivel, Aubry; Ingold, Karine; ... Schneider, Pascal 2008
add to browser selection
Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity Flatz, Lukas; Hegazy, A. N.; Bergthaler, Andréas; Verschoor, Admar; ... Pinschewer, Daniel 2010
add to browser selection
Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis Menge, Til; Lalive d'Epinay, Patrice; von Büdingen, H Christian; Genain, Claude P 2011
add to browser selection
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients Geneva University Hospitals H1N1 study group 2011
add to browser selection
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study EUSTAR 2011
add to browser selection
A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients Hottinger, Andréas; George, Anne-Claude Catherine; Bel, Michael; Favet, Laurence; ... Dietrich, Pierre-Yves 2012